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Unusual case of Progressive Multifocal Leukoencephalopathy in a Patient with Sjögren Syndrome
Clinically Presenting as Transverse Myelitis.
Ifeoma Onwubiko, MD, MPH, Kanika Taneja, MD, Nilesh Gupta, MD, Abir Mukherjee, MD
Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, Michigan

Introduction

Figures

Imaging

Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease caused
by reactivation of JC virus affecting typically subcortical and periventricular white matter
of immunocompromised hosts (HIV infection, hematologic malignancies). Cerebral
hemispheric white matter are most commonly affected by lytic infection, leading to
progressive damage to oligodendrocytes in the CNS. Neuroimaging usually highlights
scattered foci of white matter hypodensity not attributable to contrast enhancement or mass
effect. In contrast, we present an unusual case of PML predominantly affecting cervical
spinal cord and brainstem in an immunocompetent host. This is a rare subset of PML case
that can occur in association with connective tissue disorders (Sjögren in this case), SLE
being the most common. PML should be considered in the differential diagnosis of spinal
cord/brainstem lesions, particularly in the patients with connective tissue disorders.

Figure 2: H&E stain x10

Figure 3: H&E stain x20

Figure 2 and 3. H&E stains highlighting JC virus inclusion s (red arrows) and
unremarkable oligodendrocytes (blue arrow).

Case Presentation and Management

A 65-year-old female with known history of Sjögren syndrome and liver cirrhosis presented
to Emergency department with a broken ankle secondary to a four-month-old fall. She also
reported a four-week history of vertigo, hemiparesis and right sided weakness.
On examination, she was minimally responsive and obtunded. Her speech was slurred with a
right facial droop with no cough and gag reflex. There was absent and reduced muscle tone in
the right extremities and left upper extremity respectively.
Laboratory test showed high ammonia levels (47umol/L), with abnormal liver enzymes and
kidney function tests. Cerebrospinal analysis was suggestive of a traumatic tap.
Immunoglobin G antibodies to SSA/Ro, SSB/La were positive. Thyroglobulin antibodies and
Anti-nuclear antibodies were elevated.
MRI of the spine without contrast showed T2 signal abnormality involving the medulla
extending into the upper cervical cord to C2-C3 level with C3 medullary lesions. Patient
continued to clinically deteriorate, expiring eight days later.
At autopsy, gross examination of the brain revealed unremarkable cerebral hemispheres,
sinuses and spinal cord. Histological examination was suggestive of multifocal white matter
lesions in the cervical spinal cord, pons, medulla, mid brain, cerebellum and basal ganglia.
These lesions were characterized by pallor, edema, perivascular lymphocytic cuffing,
microglial nodules, influx of activated microglial and numerous oligodendroglial nuclei with
ground glass inclusions. The inclusions were immunoreactive with Simian virus-40 (SV-40),
highlighted by P53 and MIB-1 immunostains. Other areas showed moderate hypoxic
ischemic changes in the neocortex and hippocampus. These findings supported a diagnosis of
PML with moderate hypoxic ischemic changes.

Figure 1. MRI of the spine without contrast. Arrow shows T2 abnormality involving
the medulla extending into the upper cervical cord to C2-C3 level.

Discussion
Progressive multifocal leukoencephalopathy is an opportunistic demyelinating disease of the
central nervous system (CNS) caused by reactivation of the DNA viruses of the polyoma
group. It is caused by one of two polyomavirus, John Cunningham virus (JVC). The disease
predominantly affects immunocompromised hosts, including people with leukemia, HIV-1
infection, lymphomas and renal transplant.
JC virus seropositivity has been demonstrated in approximately 33%-90% of people
depending on the study and geographical location. Inciting factors to the development of
PML are the possibility of transformation of a large proportion of lymphocytes which
become unable to participate in immune responses and therapy induced immunodeficiency.
Patient with autoimmune conditions such as systemic lupus erythematosus, sarcoidosis,
rheumatoid arthritis and Sjögren's disease independent of immunotherapy could develop
PML due to disease associated lymphopenia. Although 5.2% of Sjögren syndrome have
CD4+ T-lymphocytopenia, to our knowledge, only one case of PML has been reported in a
patient with known history of the disease.
The pathophysiology could be attributed to leukocyte sequestration in enlarged spleen
arising from portal hypertension from hepatic cirrhosis leading to patients developing
leucopenia. In addition, hypogammoglobinemia sequel to liver cirrhosis contributes to
decreased immunity.
This case highlights that although PML has been documented in immunocompromised
patients, it has rarely been associated with connective tissue disorders. Awareness of this
entity is crucial for pathologists as well as physicians to consider it as differential diagnosis
of white matter lesions irrespective of the sites of neuraxial involvement.

Figure 4: SV-40 highlighting JC virus
inclusions

Figure 5: CD 163 highlighting
perivascular monocyte/macrophage
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